突觸素(SYP)卵白蛋白偶聯(lián)物
OVA Conjugated Synaptophysin (SYP)
Major synaptic vesicle protein p38
- 編號(hào)CPA425Hu21
- 物種Homo sapiens (Human，人)相同的名稱，不同的物種。
- 來(lái)源蛋白偶聯(lián)
- 原分子量-
- 緩沖液成份磷酸鹽緩沖液（pH7.4）
- 性狀凍干粉
- 純度> 90%
- 等電點(diǎn)-
- 應(yīng)用Immunogen; SDS-PAGE; WB.
如果需要有生物活性的蛋白，請(qǐng)參見(jiàn)活性蛋白。 - 下載英文說(shuō)明書(shū) 中文說(shuō)明書(shū)
- 規(guī)格10μg50μg200μg1mg5mg
- 價(jià)格¥ 792¥ 1980¥ 3960¥ 11880¥ 29700
- 欲了解實(shí)際交易價(jià)格和更多情況，請(qǐng)與當(dāng)?shù)亟?jīng)銷商聯(lián)系!
產(chǎn)品包裝(模擬)
產(chǎn)品包裝(模擬)
SDS-PAGE圖
通過(guò)ISO 9001、ISO 13485質(zhì)量體系認(rèn)證
化學(xué)式
用法
Reconstitute in PBS (pH7.4) to a concentration of 0.1-1.0 mg/mL. Do not vortex.
儲(chǔ)存
避免反復(fù)凍融。2-8°C不超過(guò)一個(gè)月，-80°C不超過(guò)12個(gè)月。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗(yàn)決定，具體方法如下：在37°C孵育48小時(shí)，沒(méi)有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi)，在適當(dāng)?shù)臈l件下存儲(chǔ)，損失率低于5%。
增值服務(wù)
相關(guān)產(chǎn)品
| 編號(hào) | 適用物種：Homo sapiens (Human，人) | 應(yīng)用(僅供研究使用，不用于臨床診斷！) |
| RPA425Hu01 | 突觸素(SYP)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| CPA425Hu21 | 突觸素(SYP)卵白蛋白偶聯(lián)物 | Immunogen; SDS-PAGE; WB. |
| PAA425Hu02 | 突觸素(SYP)多克隆抗體 | WB |
| PAA425Hu01 | 突觸素(SYP)多克隆抗體 | WB; IHC; ICC; IP. |
| PAA425Hu08 | 突觸素(SYP)多克隆抗體 | WB |
| LAA425Hu61 | 突觸素(SYP)多克隆抗體(吲哚菁綠標(biāo)記) | WB; IHC; ICC; IF. |
| MAA425Hu22 | 突觸素(SYP)單克隆抗體 | WB; IHC; ICC; IP. |
| MAA425Hu21 | 突觸素(SYP)單克隆抗體 | WB; IHC; ICC; IP. |
| SEA425Hu | 突觸素(SYP)檢測(cè)試劑盒(酶聯(lián)免疫吸附試驗(yàn)法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| CEA425Hu | 突觸素(SYP)檢測(cè)試劑盒(酶聯(lián)免疫吸附試驗(yàn)法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| LMA425Hu | 突觸素(SYP)等多因子檢測(cè)試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
| KSA425Hu01 | 突觸素(SYP)檢測(cè)試劑盒DIY材料(酶聯(lián)免疫吸附試驗(yàn)法) | Main materials for "Do It (ELISA Kit) Yourself". |
參考文獻(xiàn)
| 雜志 | 參考文獻(xiàn) |
| Neuropsychopharmacology | Increased Amyloid-β Peptide-Induced Memory Deficits in Phospholipid Transfer Protein (PLTP) Gene Knockout Mice[Nature: Source] |
| United States Application US20140378440 | BACLOFEN AND ACAMPROSATE BASED THERAPY OF NEUROLOGICAL DISORDERS Read more: http://www.faqs.org/patents/app/20130090307#ixzz3VGRXUqW9[Faqs:Source] |
| Scientific Reports | In Vivo Characterization of ARN14140, a Memantine/Galantamine-Based Multi-Target Compound for Alzheimer's Disease[pubmed:27609215] |
| IOS Press Content Library | An Intranasal Formulation of Erythropoietin (Neuro-EPO) Prevents Memory Deficits and Amyloid Toxicity in the APPSwe Transgenic Mouse Model of Alzheimer's …[articles:journal-of-alzheimers-disease] |
| University of British Columbia | Investigating the roles of SRRM4 in contribution to neuroendocrine prostate cancer progression[] |
| pharmacological research | Neuroprotection in non-transgenic and transgenic mouse models of Alzheimer's disease by positive modulation of σ1 receptors[Pubmed: 31048034] |
| Nutrients | Fermented Goat Milk Consumption Enhances Brain Molecular Functions during Iron Deficiency Anemia Recovery[Pubmed: 31591353] |
| ACS Applied Materials & Interfaces | Tunable Substrate Functionalities Direct Stem Cell Fate toward Electrophysiologically Distinguishable Neuron-like and Glial-like Cells[33356098] |
| JOURNAL OF MOLECULAR NEUROSCIENCE | Enriched Environment Minimizes Anxiety/Depressive-Like Behavior in Rats Exposed to Immobilization Stress and Augments Hippocampal Neurogenesis (In Vitro)[33492617] |